Gossamer Bio logo

Gossamer Bio

GOSS | NASDAQ
Chart Builder DCF Calculator
$10.98
+$0.01 (+0.09%)
At close: Nov 16, 2026, 4:00 PM ET
$10.98
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:39 PM ET
+0.09%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
41.5
Fundamentals Average
Market Sentiment Bullish
Moat None
Sector Rank #480/1021 (Top 47%)

Key Statistics

Market Data

Market Cap $71.7M
1D Range
10.76 11.30
52W Range
8.43 303.20

Valuation (TTM)

PE -0.24
PB -0.58
EV/EBITDA -0.30

Valuation (NTM)

Forward PE N/A
Forward PEG 0.00
Price Target $32.00
Loading financial charts...

Profile

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in...

Sector Healthcare
Industry Biotechnology
Employees 162
IPO Date Feb 8, 2019
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 10, 2026
EPS
-$7.36
Miss -94.20%
REV
$38.43M
Beat +216.00%
Next Earnings
Mar 12, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
8
Consensus
Buy
Price Target
$32.00
Upside
+191.44%
Buy (5)
Hold (2)
Sell (1)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.